Skip to main content
. 2016 Feb 2;2016(2):CD007786. doi: 10.1002/14651858.CD007786.pub3

2. Adverse events ‐ cannabinoids.

Citation Adverse events noted
Chan 1987 Nabilone orally: dizziness (18), drowsiness (24), mood alteration (5), ocular swelling and irritation (4), orthostatic hypotension (3), muscle twitching (2), increased appetite (1)
Dalzell 1986 Nabilone: hallucinations requiring withdrawal from trial (1), drowsiness (12), dizziness (8), mood changes (3), pruritis (1), dry mouth (1), vagueness (1), light‐headedness (1), increased appetite (1)
Ekert 1979 Tetrahydrocannabinol: drowsiness (4)
Ekert 1979a Tetrahydrocannabinol: drowsiness (6), mood alteration (2)